Using Cannabis to Improve Quality of Life for Multiple Myeloma Patients
NCT07225738 · RecruitingThis study looks at how using cannabis, also known as marijuana, affects the quality of life for patients with multiple myeloma who are getting chemotherapy. It aims to find out both the potential benefits and any issues that might come from cannabis use. Participants will be grouped based on their cannabis use and will share information about their experiences during treatment.
Locations and contact
This trial is running at 11 locations in the United States. 2 of them are currently recruiting.
United States11 locations · 2 recruiting
- City of Hope at Irvine LennarIrvine, CaliforniaRecruiting
- City of Hope Medical CenterDuarte, CaliforniaRecruiting
- City of Hope at ChicagoZion, IllinoisNot Yet Recruiting
- City of Hope at Long Beach ElmLong Beach, CaliforniaNot Yet Recruiting
- City of Hope at Newport Beach Fashion IslandNewport Beach, CaliforniaNot Yet Recruiting
- City of Hope Atlanta Cancer CenterNewnan, GeorgiaNot Yet Recruiting
- City of Hope SeacliffHuntington Beach, CaliforniaNot Yet Recruiting
- City of Hope South PasadenaSouth Pasadena, CaliforniaNot Yet Recruiting
- City of Hope UplandUpland, CaliforniaNot Yet Recruiting
- City of Hope West CovinaWest Covina, CaliforniaNot Yet Recruiting
- CTCA at Western Regional Medical CenterGoodyear, ArizonaNot Yet Recruiting
Who can join
Anyone 18 years or older can join this study. It is open to both men and women who have been newly diagnosed with multiple myeloma. Participants should be able to read and understand English. Some people may not be eligible, such as those who have received more than four cycles of first-line therapy or have other active cancers. The study team will confirm who can join.
What happens during the trial
Participants will be placed into one of two groups. In the first group, patients will fill out surveys and provide blood samples over the course of the study. In the second group, healthcare providers will complete a survey to provide their insights. This study does not involve any drug interventions, as it is observational.
The trial team
The trial is led by the City of Hope Medical Center, with Dr. Richard Lee as the principal investigator. The National Cancer Institute is also collaborating on this study.
Important dates
This trial started on January 21, 2026, and is expected to finish by August 22, 2030. It is currently enrolling new participants.
Additional information
The trial's ID number is NCT07225738. This is an observational study, meaning it looks at how things are without giving any treatments. About 700 people will be included in the study.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →